eAMS-PharmElectronic Asthma Management System for Pharmacies
This clinical trial is an interventional study aimed at improving asthma management in pharmacies through an electronic system. It will assess the proportion and trend of medication adjustments, asthma control assessment, and action plan creation for patients.
Pharmacy Clinical Decision Support System for Asthma Management
Asthma+6
+ Bronchial Diseases
+ Hypersensitivity
Services Research Study
Summary
Study start date: June 23, 2025
Actual date on which the first participant was enrolled.Asthma is a common long-term condition that affects many adults, and controlling it can be challenging. Despite available treatments, many people in Canada struggle with poorly controlled asthma due to several gaps in care, such as not following guidelines, not adjusting medications when needed, and not getting proper action plans or specialist referrals. This study focuses on a tool called the Electronic Asthma Management System (eAMS), which has been successful in primary care settings and aims to improve asthma management by involving pharmacists. Pharmacists are increasingly important in healthcare, and this study seeks to use the eAMS to help them provide better asthma care, potentially making it easier for patients to manage their condition and easing the load on primary care doctors. In the study, participants will use the eAMS tool, which is a web-based system that collects information about their asthma and provides tailored advice. Using a questionnaire, patients will enter details about their asthma symptoms, which the system then analyzes to offer guidance on managing their condition. The tool can recommend changes to medication and create a personalized asthma action plan. Pharmacists will use this information to support asthma patients more effectively, helping to ensure they have the right care and medications. While the study doesn't list specific risks or benefits, it aims to improve asthma control and make healthcare more efficient by involving pharmacists in chronic disease management.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.100 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Services Research Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.Over 16 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
* Eligible patients would be those who have asthma and are seen at one of the three study pharmacies during the study period * Eligible pharmacy team members would be staff (pharmacists/RPhTs/assistants/students) at any one of the three study pharmacies
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.One single intervention group is designated in this study
This study does not include a placebo group
Treatment Groups
Group I
Active ComparatorStudy Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 3 locations
LiveWell Pharmacy
Niagara Falls, CanadaWestmount Place Pharmacy
Waterloo, Canada